ATE113056T1 - Künstliche rezeptor-analoge. - Google Patents

Künstliche rezeptor-analoge.

Info

Publication number
ATE113056T1
ATE113056T1 AT89909545T AT89909545T ATE113056T1 AT E113056 T1 ATE113056 T1 AT E113056T1 AT 89909545 T AT89909545 T AT 89909545T AT 89909545 T AT89909545 T AT 89909545T AT E113056 T1 ATE113056 T1 AT E113056T1
Authority
AT
Austria
Prior art keywords
pct
galabiose
artificial receptor
sec
receptor analogues
Prior art date
Application number
AT89909545T
Other languages
English (en)
Inventor
Hans Goeran Magnusson
Jan Olof Kihlberg
Original Assignee
Symbicom Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbicom Ab filed Critical Symbicom Ab
Application granted granted Critical
Publication of ATE113056T1 publication Critical patent/ATE113056T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Prostheses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT89909545T 1988-08-12 1989-08-11 Künstliche rezeptor-analoge. ATE113056T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK455088A DK455088D0 (da) 1988-08-12 1988-08-12 Syntetiske receptoranaloger

Publications (1)

Publication Number Publication Date
ATE113056T1 true ATE113056T1 (de) 1994-11-15

Family

ID=8134551

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89909545T ATE113056T1 (de) 1988-08-12 1989-08-11 Künstliche rezeptor-analoge.

Country Status (12)

Country Link
US (1) US5474986A (de)
EP (1) EP0428605B1 (de)
JP (1) JPH04506509A (de)
KR (1) KR900701807A (de)
AT (1) ATE113056T1 (de)
AU (1) AU634976B2 (de)
CA (1) CA1332234C (de)
DE (1) DE68918944T2 (de)
DK (1) DK455088D0 (de)
FI (1) FI93016C (de)
IL (1) IL91269A (de)
WO (1) WO1990001488A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4119472A1 (de) * 1991-06-13 1992-12-17 Merck Patent Gmbh Verfahren zur stereoselektiven herstellung von gal-(alpha)(1-3)/gal-(beta)(1-4)/glcnac-trisacchariden und von neuen (beta)(1-3)-verknuepften oligolactosaminen ueber neue partiell alkylierte glykale
US5409902A (en) * 1991-12-31 1995-04-25 Lever Brothers Company Oral hygiene compositions containing glyceroglycolipids as antiplaque compounds
EP0601417A3 (de) * 1992-12-11 1998-07-01 Hoechst Aktiengesellschaft Physiologisch verträglicher und physiologisch abbaubarer, Kohlenhydratrezeptorblocker auf Polymerbasis, ein Verfahren zu seiner Herstellung und seine Verwendung
TW307775B (en) * 1994-02-15 1997-06-11 Novartis Erfind Verwalt Gmbh Unsaturated carbohydrate derivatives, polymers thereof and their use
US6596707B2 (en) * 2001-05-24 2003-07-22 Abbott Laboratories Monovalent saccharides and uses thereof
US7790010B2 (en) * 2002-12-20 2010-09-07 University Of Maryland, College Park Spatially selective deposition of polysaccharide layer onto patterned template
EP2497478A3 (de) * 2003-12-05 2012-11-07 Children's Hospital Medical Center Oligosaccarid-Zusammensetzungen und ihre Verwendung bei der Behandlung von Infektionen
EP2185931B1 (de) 2007-09-07 2013-07-10 Children's Hospital Medical Center Verwendung von secretor-, lewis- und sialyl-antigen-konzentrationen als krankheitsvorhersage-indikatoren
JP2012532195A (ja) 2009-07-06 2012-12-13 チルドレンズ ホスピタル メディカル センター 乳オリゴ糖による炎症の阻害
JP6187893B2 (ja) * 2011-07-08 2017-08-30 群栄化学工業株式会社 保湿剤の製造方法
US10626460B2 (en) 2013-02-21 2020-04-21 Children's Hospital Medical Center Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
WO2016176484A1 (en) 2015-04-28 2016-11-03 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
EP3732186A1 (de) 2017-12-29 2020-11-04 GlycoMimetics, Inc. Heterobifunktionale inhibitoren von e-selektin und galectin-3
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
CA3122321A1 (en) 2018-12-27 2020-07-02 Glycomimetics, Inc. Galectin-3 inhibiting c-glycosides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8001748L (sv) * 1980-03-05 1981-09-06 Kaellenius Gunilla Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
EP0089940A1 (de) * 1982-03-23 1983-09-28 BioCarp AB Oligosaccharide umfassende Zusammensetzung für therapeutische oder diagnostische Verwendung
SE8203925D0 (sv) * 1982-06-23 1982-06-23 Svenska Sockerfabriks Ab New and novel glycosides, glycoconjugates and processes for their preparation
SE8304007D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
SE8406626D0 (sv) * 1984-12-27 1984-12-27 Bio Carb Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte anvendning av sadan forening och komposition for terapeutisk behandling och isolering av shigatoxin
DK17685D0 (da) * 1985-01-14 1985-01-14 Hans Goeran Magnusson Glycosidderivater

Also Published As

Publication number Publication date
AU634976B2 (en) 1993-03-11
IL91269A (en) 1994-11-11
DE68918944T2 (de) 1995-05-11
EP0428605A1 (de) 1991-05-29
FI93016C (fi) 1995-02-10
FI93016B (fi) 1994-10-31
JPH04506509A (ja) 1992-11-12
DE68918944D1 (de) 1994-11-24
CA1332234C (en) 1994-10-04
US5474986A (en) 1995-12-12
KR900701807A (ko) 1990-12-04
DK455088D0 (da) 1988-08-12
WO1990001488A1 (en) 1990-02-22
AU4074989A (en) 1990-03-05
FI910653A0 (fi) 1991-02-11
EP0428605B1 (de) 1994-10-19

Similar Documents

Publication Publication Date Title
ES2131496T3 (es) Mejoras relativas a derivados glicopeptidicos.
DE68918944D1 (de) Künstliche rezeptor-analoge.
DK0611522T3 (da) Synergistiske mikrobicide sammensætninger
NO891909D0 (no) Implantat for brytningskorreksjon i et oeyes forkammer.
SE8503680D0 (sv) Indolderivat
MY129994A (en) Novel siloxane derivatives, producing method thereof and agents including siloxane derivative
NO306609B1 (no) I det vesentlige sfaerisk vateritt og fremgangsmåte for fremstilling derav
FI874189L (fi) Epimeerisen jakaantumisen säätelymenetelmä pregnaanijohdannaisten 16,17-asetaalien valmistuksessa
ES2080140T3 (es) Derivados de eritromicina.
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
NO953353D0 (no) Xantinderivater som adenosin-A -reseptorantagonister
CS9100438A2 (en) New derivative of beta-phenylisoserine, method of its preparation and its application
ATE141796T1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
ES2028871T3 (es) Un procedimiento para la preparacion de un glicosido de antraciclina. .
NZ234451A (en) Benzofuran-substituted 2-imidazoline derivatives and pharmaceutical compositions
GR3005566T3 (de)
AU1786988A (en) Isoxazoles with nootropic activity
엄인웅 et al. Open reduction of fractured mandibular condyles: overview
ATE100696T1 (de) Endoprothese.
IT210946Z2 (it) Attacco ammortizzato per protesi dentaria.
IT8623729V0 (it) Attacco ammortizzato per protesi dentaria.
NO974687L (no) Kondenserte <beta>-carboliner
IT1214294B (it) Protesi anatomica femorale perfezionata, applicabile senza cementazione.
IT8763269V0 (it) Protesi anatomica femorale perfezionata, applicabile senza cementazione.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee